How Roivant Sciences Ltd. stacks up

ROIV · against 89 other Healthcare companies of similar size

Overall

28/ 100

Near the bottom of its peers.

Ranked #88 of 90 · scores higher than 2% of peers

Bars: peers in each 10-point band of the overall score

3 peers with an overall score of 20–29, including ROIV · Click a bar to see the companies

The four scores behind it

Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)

Valuation#82 of 90Score 8 / 100 · beats 0%Growth#87 of 87Score 5 / 100 · beats 0%Profitability#90 of 90Score 6 / 100 · beats 0%Risk#1 of 90Lower relative risk · safety 93 · beats 100%

Ranking by overall score

Top 5 and the companies ranked around ROIV

Rank	Company	Market cap	Overall	Valuation	Growth	Profitability	Risk
1	Incyte CorporationINCY · US-listed	23.8B USD	84	82	82	98	0 / 2
2	Hansoh Pharmaceutical Group Company Limited3692.HK · Hong Kong	193.6B HKD (≈$24.8B)	78	64	74	97	0 / 2
2	Orion OyjORNAV.HE · Europe	13.9B EUR (≈$15.3B)	78	68	75	99	0 / 2
4	Pro Medicus LimitedPME.AX · Australia & NZ	20.0B AUD (≈$13.2B)	77	38	87	99	0 / 2
5	Astellas Pharma Inc.4503.T · Japan	4.61T JPY (≈$31.3B)	76	93	89	87	1 / 2
⋯
83	Viatris Inc.VTRS · US-listed	21.7B USD	32	52	26	31	2 / 2
85	Tempus AI, Inc.TEM · US-listed	14.0B USD	31	8	88	25	2 / 2
86	Baxter International Inc.BAX · US-listed	13.2B USD	30	41	33	33	2 / 2
86	BridgeBio Pharma, Inc.BBIO · US-listed	14.5B USD	30	8	96	10	2 / 2
88	Roivant Sciences Ltd.ROIV · US-listed	26.0B USD	28	8	5	6	0 / 2
89	Guardant Health, Inc.GH · US-listed	23.5B USD	27	8	82	14	2 / 2
90	Centene CorporationCNC · US-listed	33.3B USD	24	8	43	27	2 / 2

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…